Skip to content

Net margin at other companies

Eli Lilly logo
Eli LillyLLY
35%+12.3pp
Johnson & Johnson logo
Johnson & JohnsonJNJ
21.8%-2.6pp
Jazz Pharmaceuticals logo
Jazz PharmaceuticalsJAZZ
-8.9%-20.5pp
Axsome Therapeutics logo
Axsome TherapeuticsAXSM
-26.6%-9.8pp
Praxis Precision Medicines, Inc. logo
Praxis Precision Medicines, Inc.PRAX
-3,658.5%-1,388pp
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
21.6%+8.9pp

Other financials

Income statement

See full
Revenue--100%
Operating income-$112.3M-54.4%
Net income-$102.3M-57.3%
EPS (diluted)-$1.17-41.0%

Balance sheet

See full
Cash & equivalents$545.9M+368%
Total debt$7.5M-13.6%
Total equity$1.3B+90.0%
Total assets$1.4B+86.6%

Cash flow

See full
Operating cash flow-$88.9M-44.2%
CapEx$133.0K+209%
Free cash flow-$89.0M-44.3%

Valuation

See full
Market cap$5.11B+116%
Enterprise value$4.58B+104%

Profitability

See full
Operating margin-4,974.3%
FCF margin-3,732.2%

Returns & leverage

See full
Return on equity-37.5%+8.7pp
Debt / equity0.0×
Current ratio27.8×+10.1×

Where this comes from

Calculated from Xenon Pharmaceuticals’s reported figures.

Based on trailing twelve months.

The official record: Xenon Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Xenon Pharmaceuticals's net margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Xenon Pharmaceuticals's net margin?
Xenon Pharmaceuticals (XENE) reported net margin of -4,612.1% in Q4 2025.
What is the long-term trend for Xenon Pharmaceuticals's net margin?
Over 3 years (2020 to 2025), Xenon Pharmaceuticals's net margin has grown at a 271.9% compound annual growth rate (CAGR), from -89.7% to -4,612.1%.
What does net margin mean?
Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.